Cargando…
The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets
During the past three decades, over thirty-five anti-HIV-1 therapies have been developed for use in humans and the progression from monotherapeutic treatment regimens to today's highly active combination antiretroviral therapies has had a dramatic impact on disease progression in HIV-1-infected...
Autores principales: | Hartman, Tracy L., Buckheit, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400388/ https://www.ncbi.nlm.nih.gov/pubmed/22848825 http://dx.doi.org/10.1155/2012/401965 |
Ejemplares similares
-
Antiretroviral therapy targeting HIV-1 viral infectivity factor; in silico approach
por: Karau, Muriira G, et al.
Publicado: (2009) -
Next generation of antiretroviral agents targeting the RNA binding site of the HIV-1 cellular cofactor DDX3: an innovative therapeutic approach
por: Maga, Giovanni, et al.
Publicado: (2012) -
Cellular Factors Targeting HIV-1 Transcription and Viral RNA Transcripts
por: Nchioua, Rayhane, et al.
Publicado: (2020) -
Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014) -
Novel Anti-Cancer Agents and Cellular Targets and Their Mechanism(s) of Action
por: Allison, Simon J.
Publicado: (2022)